FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2102673109> ?p ?o ?g. }

• W2102673109 endingPage "58" @default.
• W2102673109 startingPage "58" @default.
• W2102673109 abstract "(Buccalin ®) is a Bacterial Lysates (BL) that belongs to a family of immune-stimulators, developed more than 30 years ago and it still has a role in the prophylaxis of Recurrent Respiratory Tract Infections (RRTI). However, original studies were conducted with an approach that does not seem to be aligned with the present methodologies. In addition, concomitant therapies substantially improved in the last decades. These two reasons strongly suggested to update our knowledge on the capacity of this bacterial lysate (Buccalin ®) to reduce the number of days with infectious episodes in patients with RRTI. A double blind, placebo-controlled, randomized, multicentre study was programmed (EudraCT code: 2011-005187-25). The reduction of the number of days with infectious episodes (IE) was the primary endpoint. Secondary endpoints were the number of IE, the use of concomitant drugs, the efficacy on signs and symptoms of RRTI and the safety of the drug. Patients were treated according to the registered schedule and were followed up for a period of 6 months. From a cohort of 188 patients eligible for the study, 90 were included in the active group and 88 in the placebo group. The study was completed in 170 patients. A significant reduction of the number of days with IE was observed (6.57 days in the active group and 7.47 in the placebo group). Secondary endpoints were only partially achieved. No virtual adverse events related to the treatment were recorded. The administration of bacterial lysate (Buccalin ®) in patients with RRTI had the capacity to significantly reduce the number of days with IE in a multicentre, randomized, placebo controlled, clinical study. The treatment was safe. Of note, all patients were free to be treated with the best concomitant therapies. In these conditions, the positive results observed demonstrated that this bacterial lysate has maintained its capacity of reducing the days with infections in patients with RRTI, also in association to the concomitant therapies available nowadays." @default.
• W2102673109 created "2016-06-24" @default.
• W2102673109 creator A5009167884 @default.
• W2102673109 creator A5021940532 @default.
• W2102673109 creator A5029195837 @default.
• W2102673109 creator A5033156985 @default.
• W2102673109 creator A5036707809 @default.
• W2102673109 creator A5037521453 @default.
• W2102673109 creator A5049098129 @default.
• W2102673109 creator A5049925872 @default.
• W2102673109 creator A5064504205 @default.
• W2102673109 creator A5087030380 @default.
• W2102673109 date "2014-01-01" @default.
• W2102673109 modified "2023-09-27" @default.
• W2102673109 title "Clinical efficacy and tolerability of an immune-stimulant* constituted by inactivated bacterial bodies in the prophylaxis of infectious episodes of airways: a double blind, placebo-controlled, randomized, multicentre study" @default.
• W2102673109 cites W113041032 @default.
• W2102673109 cites W13723910 @default.
• W2102673109 cites W1981981350 @default.
• W2102673109 cites W2019502163 @default.
• W2102673109 cites W2024666424 @default.
• W2102673109 cites W2026676002 @default.
• W2102673109 cites W2032872959 @default.
• W2102673109 cites W2061668998 @default.
• W2102673109 cites W2062352006 @default.
• W2102673109 cites W2085790060 @default.
• W2102673109 cites W2119986866 @default.
• W2102673109 cites W2134901034 @default.
• W2102673109 cites W2134927984 @default.
• W2102673109 cites W2388088975 @default.
• W2102673109 cites W2395040222 @default.
• W2102673109 cites W2405151702 @default.
• W2102673109 cites W2415080409 @default.
• W2102673109 cites W2433997994 @default.
• W2102673109 cites W2462091951 @default.
• W2102673109 cites W2464807598 @default.
• W2102673109 doi "https://doi.org/10.1186/2049-6958-9-58" @default.
• W2102673109 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4334598" @default.
• W2102673109 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25699178" @default.
• W2102673109 hasPublicationYear "2014" @default.
• W2102673109 type Work @default.
• W2102673109 sameAs 2102673109 @default.
• W2102673109 citedByCount "4" @default.
• W2102673109 countsByYear W21026731092016 @default.
• W2102673109 countsByYear W21026731092020 @default.
• W2102673109 countsByYear W21026731092021 @default.
• W2102673109 countsByYear W21026731092023 @default.
• W2102673109 crossrefType "journal-article" @default.
• W2102673109 hasAuthorship W2102673109A5009167884 @default.
• W2102673109 hasAuthorship W2102673109A5021940532 @default.
• W2102673109 hasAuthorship W2102673109A5029195837 @default.
• W2102673109 hasAuthorship W2102673109A5033156985 @default.
• W2102673109 hasAuthorship W2102673109A5036707809 @default.
• W2102673109 hasAuthorship W2102673109A5037521453 @default.
• W2102673109 hasAuthorship W2102673109A5049098129 @default.
• W2102673109 hasAuthorship W2102673109A5049925872 @default.
• W2102673109 hasAuthorship W2102673109A5064504205 @default.
• W2102673109 hasAuthorship W2102673109A5087030380 @default.
• W2102673109 hasBestOaLocation W21026731091 @default.
• W2102673109 hasConcept C126322002 @default.
• W2102673109 hasConcept C141071460 @default.
• W2102673109 hasConcept C142724271 @default.
• W2102673109 hasConcept C168563851 @default.
• W2102673109 hasConcept C197934379 @default.
• W2102673109 hasConcept C203092338 @default.
• W2102673109 hasConcept C204787440 @default.
• W2102673109 hasConcept C27081682 @default.
• W2102673109 hasConcept C2776012195 @default.
• W2102673109 hasConcept C2778375690 @default.
• W2102673109 hasConcept C2779384505 @default.
• W2102673109 hasConcept C534529494 @default.
• W2102673109 hasConcept C535046627 @default.
• W2102673109 hasConcept C71924100 @default.
• W2102673109 hasConceptScore W2102673109C126322002 @default.
• W2102673109 hasConceptScore W2102673109C141071460 @default.
• W2102673109 hasConceptScore W2102673109C142724271 @default.
• W2102673109 hasConceptScore W2102673109C168563851 @default.
• W2102673109 hasConceptScore W2102673109C197934379 @default.
• W2102673109 hasConceptScore W2102673109C203092338 @default.
• W2102673109 hasConceptScore W2102673109C204787440 @default.
• W2102673109 hasConceptScore W2102673109C27081682 @default.
• W2102673109 hasConceptScore W2102673109C2776012195 @default.
• W2102673109 hasConceptScore W2102673109C2778375690 @default.
• W2102673109 hasConceptScore W2102673109C2779384505 @default.
• W2102673109 hasConceptScore W2102673109C534529494 @default.
• W2102673109 hasConceptScore W2102673109C535046627 @default.
• W2102673109 hasConceptScore W2102673109C71924100 @default.
• W2102673109 hasIssue "1" @default.
• W2102673109 hasLocation W21026731091 @default.
• W2102673109 hasLocation W21026731092 @default.
• W2102673109 hasLocation W21026731093 @default.
• W2102673109 hasLocation W21026731094 @default.
• W2102673109 hasOpenAccess W2102673109 @default.
• W2102673109 hasPrimaryLocation W21026731091 @default.
• W2102673109 hasRelatedWork W1966047811 @default.
• W2102673109 hasRelatedWork W2003042623 @default.
• W2102673109 hasRelatedWork W2006519956 @default.
• W2102673109 hasRelatedWork W202460821 @default.
• W2102673109 hasRelatedWork W2030348591 @default.

• next